Recent Updates
Recently added Catalysts
SMTI Positive Sentiment

CellerateRX® Surgical Powder Cost-Effectiveness Analysis in Spine Surgery

Key Takeaway: The article discusses a cost-effectiveness analysis of CellerateRX® Surgical Powder in spine surgery, presented by Dr. Vivek Mohan. The analysis aims to evaluate the economic benefits of using this product in surgical settings. The findings could potentially influence future practices in spine surgery.
Price reaction · baseline $19.425 (2026-02-12 close) · hit pre-market · 3 other SMTI headline(s) in the window, move may be shared
day 0 close · peak
-2.7%

Market Sentiment Analysis

POSITIVE FACTORS

  • CellerateRX® Surgical Powder shows promise in spine surgery.
  • The analysis may lead to improved cost-effectiveness in surgical procedures.

Full Press Release Details

• Last Updated on February 13, 2026
Presenter: Vivek Mohan, MD
Important Notice: The contents of the website such as text, graphics, images, and other materials contained on the website ("Content") are for informational purposes only. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. The content is not intended to substitute for manufacturer instructions nor create new product claims. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or product usage. Please refer to our Terms of Use .

Related Posts

• Last Updated on April 7, 2026
Prodromos Ververeli, MD & Asaf Yalif, MD & Rory Snepar, DO
• Last Updated on April 7, 2026
Prodromos Ververeli, MD & Asaf Yalif, MD & Rory Snepar, DO
• Last Updated on April 7, 2026
Prodromos Ververeli, MD & Asaf Yalif, MD & Rory Snepar, DO
• About Sanara
• Board of Directors
• Surgical Products
• Code of Conduct
• Stock Quote
• Press Releases
• SEC Filings
© 2026 All Rights Reserved. Sanara MedTech Inc.

Frequently Asked Questions

What is CellerateRX® Surgical Powder?

CellerateRX® Surgical Powder is a product used in surgical procedures, particularly in spine surgery.

Who presented the cost-effectiveness analysis?

The analysis was presented by Dr. Vivek Mohan.

What is the purpose of the analysis?

The analysis aims to evaluate the economic benefits of CellerateRX® in surgical settings.

Last updated: Feb 13, 2026